- Home
- PROK vs SWBI Comparison
PROK vs SWBI Comparison
Compare PROK & SWBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PROK | SWBI |
|---|---|---|
| Founded | 2015 | 1852 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Ordnance And Accessories |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 417.1M | 453.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PROK | SWBI |
|---|---|---|
| Price | $2.48 | $10.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $7.40 | ★ $11.00 |
| AVG Volume (30 Days) | ★ 1.3M | 630.4K |
| Earning Date | 11-10-2025 | 12-04-2025 |
| Dividend Yield | N/A | ★ 5.07% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.21 |
| Revenue | $744,000.00 | ★ $466,396,000.00 |
| Revenue This Year | $956.51 | $2.62 |
| Revenue Next Year | N/A | $3.23 |
| P/E Ratio | ★ N/A | $49.02 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.46 | $7.73 |
| 52 Week High | $7.13 | $11.50 |
Technical Indicators
Market Signals| Indicator | PROK | SWBI |
|---|---|---|
| Relative Strength Index (RSI) | 54.72 | 57.97 |
| Support Level | $2.10 | $9.85 |
| Resistance Level | $2.29 | $10.38 |
| Average True Range (ATR) | 0.17 | 0.21 |
| MACD | 0.01 | -0.05 |
| Stochastic Oscillator | 76.53 | 47.25 |
Price Performance
Historical ComparisonAbout PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About SWBI Smith & Wesson Brands Inc.
Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.